Frontlight ResearchEarly access
Trial site
Shanghai Fengxian District Central Hospital
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Obesity2 trials
- Type 2 diabetes2 trials
- Alzheimer disease1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Chronic kidney disease1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Obstructive sleep apnoea1 trial
- Ovarian cancer1 trial
- Phase
- Early phase 11 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Completed3 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Shanghai Fengxian District Central Hospital2 trials
- Amway (China) R&D Center1 trial
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial
- Shanghai 6th People's Hospital1 trial
- Shanghai Pharmaceuticals Holding Co., Ltd1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026